rs7545121

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_024420.3(PLA2G4A):​c.2118+2825A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.395 in 152,162 control chromosomes in the GnomAD database, including 14,174 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 14174 hom., cov: 33)

Consequence

PLA2G4A
NM_024420.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0810

Publications

12 publications found
Variant links:
Genes affected
PLA2G4A (HGNC:9035): (phospholipase A2 group IVA) This gene encodes a member of the cytosolic phospholipase A2 group IV family. The enzyme catalyzes the hydrolysis of membrane phospholipids to release arachidonic acid which is subsequently metabolized into eicosanoids. Eicosanoids, including prostaglandins and leukotrienes, are lipid-based cellular hormones that regulate hemodynamics, inflammatory responses, and other intracellular pathways. The hydrolysis reaction also produces lysophospholipids that are converted into platelet-activating factor. The enzyme is activated by increased intracellular Ca(2+) levels and phosphorylation, resulting in its translocation from the cytosol and nucleus to perinuclear membrane vesicles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
PLA2G4A Gene-Disease associations (from GenCC):
  • cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen
  • cryptogenic multifocal ulcerous stenosing enteritis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.566 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024420.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLA2G4A
NM_024420.3
MANE Select
c.2118+2825A>G
intron
N/ANP_077734.2P47712
PLA2G4A
NM_001311193.2
c.1938+2825A>G
intron
N/ANP_001298122.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLA2G4A
ENST00000367466.4
TSL:1 MANE Select
c.2118+2825A>G
intron
N/AENSP00000356436.3P47712
PLA2G4A
ENST00000851114.1
c.2118+2825A>G
intron
N/AENSP00000521173.1
PLA2G4A
ENST00000851115.1
c.2118+2825A>G
intron
N/AENSP00000521174.1

Frequencies

GnomAD3 genomes
AF:
0.395
AC:
60060
AN:
152040
Hom.:
14157
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.121
Gnomad AMI
AF:
0.520
Gnomad AMR
AF:
0.387
Gnomad ASJ
AF:
0.527
Gnomad EAS
AF:
0.583
Gnomad SAS
AF:
0.440
Gnomad FIN
AF:
0.555
Gnomad MID
AF:
0.414
Gnomad NFE
AF:
0.513
Gnomad OTH
AF:
0.396
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.395
AC:
60094
AN:
152162
Hom.:
14174
Cov.:
33
AF XY:
0.399
AC XY:
29692
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.121
AC:
5032
AN:
41548
American (AMR)
AF:
0.387
AC:
5923
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.527
AC:
1828
AN:
3470
East Asian (EAS)
AF:
0.584
AC:
3010
AN:
5158
South Asian (SAS)
AF:
0.443
AC:
2134
AN:
4818
European-Finnish (FIN)
AF:
0.555
AC:
5867
AN:
10580
Middle Eastern (MID)
AF:
0.405
AC:
119
AN:
294
European-Non Finnish (NFE)
AF:
0.513
AC:
34856
AN:
67976
Other (OTH)
AF:
0.403
AC:
852
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1703
3405
5108
6810
8513
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.473
Hom.:
30911
Bravo
AF:
0.368
Asia WGS
AF:
0.468
AC:
1622
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
12
DANN
Benign
0.74
PhyloP100
0.081
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7545121; hg19: chr1-186951429; COSMIC: COSV66552755; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.